Skip to main content

QUALYS, INC.

For the period ended Sep 30, 2026. Filed Nov 9, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 9, 2026

QLYS$175.11-13.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

Nine Months EndedSeptember 30,
20262025
Cash flow from operating activities:
Net income$160,222$145,170
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense9,52211,353
Provision for credit losses5361,110
Impairment of property and equipment624—
Impairment of non-marketable securities1,967—
Stock-based compensation, net of amounts capitalized58,37356,313
Accretion of discount on marketable securities, net(1,117)(2,799)
Deferred income taxes6,9896,724
Changes in operating assets and liabilities:
Accounts receivable21,59235,023
Prepaid expenses and other assets(8,563)(13,402)
Accounts payable2,102591
Accrued liabilities and other noncurrent liabilities(4,541)1,568
Deferred revenues8,978(7,910)
Net cash provided by operating activities256,684233,741
Cash flow from investing activities:
Purchases of marketable securities(203,815)(275,379)
Sales and maturities of marketable securities194,114182,322
Purchases of property and equipment(7,182)(4,266)
Net cash used in investing activities(16,883)(97,323)
Cash flow from financing activities:
Repurchase of common stock(185,628)(138,754)
Proceeds from exercise of stock options65,6158,856
Payments for taxes related to net share settlement of equity awards(19,506)(20,200)
Proceeds from issuance of common stock through employee stock purchase plan6,6516,751
Net cash used in financing activities(132,868)(143,347)
Net increase (decrease) in cash, cash equivalents and restricted cash106,933(6,929)
Cash, cash equivalents and restricted cash at beginning of period251,458233,382
Cash, cash equivalents and restricted cash at end of period$358,391$226,453
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.